ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,031,000 | +327.8% | 53,300 | +338.9% | 0.05% | +380.0% |
| Q2 2022 | $241,000 | -57.6% | 12,143 | -36.4% | 0.01% | -50.0% |
| Q1 2022 | $568,000 | +43.1% | 19,082 | +11.7% | 0.02% | +42.9% |
| Q4 2021 | $397,000 | -25.5% | 17,082 | 0.0% | 0.01% | -39.1% |
| Q3 2021 | $533,000 | +2.5% | 17,082 | +15.6% | 0.02% | +9.5% |
| Q2 2021 | $520,000 | -11.0% | 14,774 | -10.9% | 0.02% | -12.5% |
| Q1 2021 | $584,000 | +81.4% | 16,574 | +93.3% | 0.02% | +100.0% |
| Q4 2020 | $322,000 | -91.8% | 8,574 | -92.7% | 0.01% | -93.5% |
| Q3 2020 | $3,930,000 | – | 117,800 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |